Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Equity (2016 - 2021)

Syndax Pharmaceuticals (SNDX) has disclosed Return on Equity for 6 consecutive years, with 0.1% as the latest value for Q3 2021.

  • For Q3 2021, Return on Equity rose 37.0% year-over-year to 0.1%; the TTM value through Sep 2021 reached 0.1%, up 37.0%, while the annual FY2025 figure was 1.42%, 67.0% down from the prior year.
  • Return on Equity hit 0.1% in Q3 2021 for Syndax Pharmaceuticals, up from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.1% in Q3 2021 and bottomed at 1.52% in Q4 2019.
  • Average Return on Equity over 5 years is 0.77%, with a median of 0.6% recorded in 2017.
  • Year-over-year, Return on Equity crashed -97bps in 2017 and then surged 115bps in 2020.
  • Syndax Pharmaceuticals' Return on Equity stood at 0.6% in 2017, then tumbled by -115bps to 1.29% in 2018, then dropped by -18bps to 1.52% in 2019, then soared by 76bps to 0.37% in 2020, then skyrocketed by 74bps to 0.1% in 2021.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.1%, 0.18%, and 0.23% for Q3 2021, Q2 2021, and Q1 2021 respectively.